Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes

Receptor for advanced glycation end-products (RAGE) regulation of adiposity and adiponectin is associated with atherogenesis in apoE-deficient mouse

(2010) Hiroki Ueno et al.   ATHEROSCLEROSIS

Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes

(2009) H.L. Tam et al.   ATHEROSCLEROSIS

Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer’s disease

(2009) Ling Zhang et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

RAGE: a novel biological and genetic marker for vascular disease

(2009) Anastasia Z. Kalea et al.   CLINICAL SCIENCE

Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications

(2009) Francesca Santilli et al.   CURRENT MEDICINAL CHEMISTRY

Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene

(2009) Anastasia Z. Kalea et al.   FASEB JOURNAL

Independent determinants of soluble form of receptor for advanced glycation end products in elderly hypertensive patients

(2009) Kazuo Nakamura et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases

(2009) H. Maillard-Lefebvre et al.   RHEUMATOLOGY

Calcium-regulated intramembrane proteolysis of the RAGE receptor

(2008) Arnaud Galichet et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)

(2008) Angela Raucci et al.   FASEB JOURNAL

Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population

(2008) Giuseppe Danilo Norata et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications

(2007) Giuseppina Basta   ATHEROSCLEROSIS

Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes

(2007) Kazuo Nakamura et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Identification, classification, and expression of RAGE gene splice variants

(2007) Barry I. Hudson et al.   FASEB JOURNAL